BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24188688)

  • 1. Fatal oxaliplatin-induced thrombotic thrombocytopenic purpura: a case report.
    Baretta Z; Falci C; Piva E; Conte P
    Clin Colorectal Cancer; 2013 Dec; 12(4):294-6. PubMed ID: 24188688
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxaliplatin-induced thrombotic thrombocytopenic purpura: case report and literature review.
    Niu J; Mims MP
    J Clin Oncol; 2012 Nov; 30(31):e312-4. PubMed ID: 22987080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
    Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute oxaliplatin-induced thrombotic thrombocytopenic purpura: a case report and results from a cytoflourimetric assay of platelet fibrinogen receptor.
    Lucchesi A; Carloni S; Cangini D; Frassineti GL; Casadei Gardini A
    J Clin Oncol; 2013 Jun; 31(16):2061-2. PubMed ID: 23610122
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxaliplatin-induced Evan's syndrome.
    Earle CC; Chen WY; Ryan DP; Mayer RJ
    Br J Cancer; 2001 Feb; 84(3):441. PubMed ID: 11161414
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxaliplatin-induced renal tubular vacuolization.
    Joybari AY; Sarbaz S; Azadeh P; Mirafsharieh SA; Rahbari A; Farasatinasab M; Mokhtari M
    Ann Pharmacother; 2014 Jun; 48(6):796-800. PubMed ID: 24615628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent priapism related to oxaliplatin infusion.
    Adenis A; Mailliez A; Rigot JM; Gamelin L; Vanhuyse M; Gamelin E
    J Clin Oncol; 2008 Feb; 26(6):1016-7. PubMed ID: 18281680
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxaliplatin-mediated autoimmune thrombocytopenia.
    Saif MW; The A; Ledbetter L
    Clin Colorectal Cancer; 2009 Jan; 8(1):61-2. PubMed ID: 19203900
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
    Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
    Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
    Junker A; Kretzschmar A; Böhm U; Tannapfel A; Langenbahn D; Pieck AC; Jaehde U
    Med Monatsschr Pharm; 2004 Oct; 27(10):349-52. PubMed ID: 15527179
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed urticaria with oxaliplatin.
    Villée C; Tennstedt D; Marot L; Goossens A; Baeck M
    Contact Dermatitis; 2010 Jul; 63(1):50-3. PubMed ID: 20597935
    [No Abstract]   [Full Text] [Related]  

  • 13. Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report.
    Santodirocco M; Lombardi V; Fesce C; Palumbo G; Capalbo S; Landriscina M
    Acta Oncol; 2008; 47(8):1602-4. PubMed ID: 18607839
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
    Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
    Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of bone marrow necrosis with thrombotic thrombocytopenic purpura as a manifestation of occult colon cancer.
    Lee JL; Lee JH; Kim MK; Cho HS; Bae YK; Cho KH; Bae SH; Ryoo HM; Lee KH; Hyun MS
    Jpn J Clin Oncol; 2004 Aug; 34(8):476-80. PubMed ID: 15371467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
    Shao YY; Hong RL
    Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal diffuse alveolar damage associated with oxaliplatin administration.
    Watkins J; Slade JH; Phan A; Eng C; Weissferdt A; Overman MJ
    Clin Colorectal Cancer; 2011 Sep; 10(3):198-202. PubMed ID: 21855043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylaxis produced by oxaliplatin.
    González-Mahave I; Lobera Iabairu T; Blasco Sarramián A; del Pozo Gil MD; Zorrilla M; Vélez de Mendizábal E
    J Investig Allergol Clin Immunol; 2005; 15(1):75-7. PubMed ID: 15864887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden hearing loss due to oxaliplatin use in a patient with colon cancer.
    Güvenç MG; Dizdar D; Dizdar SK; Okutur SK; Demir G
    J Chemother; 2016 Aug; 28(4):341-2. PubMed ID: 25872564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia.
    Lacotte L; Thierry A; Delwail V; Dreyfus B; Guilhot F
    Acta Haematol; 2000; 102(3):160-2. PubMed ID: 10692682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.